<?xml version="1.0" encoding="UTF-8"?>
<ref id="B76">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Edelman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Wasserman</surname>
    <given-names>S. S.</given-names>
   </name>
   <name>
    <surname>Bodison</surname>
    <given-names>S. A.</given-names>
   </name>
   <name>
    <surname>Putnak</surname>
    <given-names>R. J.</given-names>
   </name>
   <name>
    <surname>Eckels</surname>
    <given-names>K. H.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>D.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2003</year>). 
  <article-title>Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine</article-title>. 
  <source>Am. J. Trop. Med. Hyg.</source>
  <volume>69</volume>(
  <issue>6 Suppl.</issue>), 
  <fpage>48</fpage>â€“
  <lpage>60</lpage>. 
  <pub-id pub-id-type="doi">10.4269/ajtmh.2003.69.48</pub-id>
  <?supplied-pmid 14740955?>
  <pub-id pub-id-type="pmid">14740955</pub-id>
 </mixed-citation>
</ref>
